NCT03007602

Brief Summary

Hematologic malignancy is a tumor of myeloid or lymphatic cells that affects lymph nodes with the involvement of blood, bone marrow or other organs.There are various treatment options for hematological malignancies ranging from follow-up to single or multiple agent chemotherapy, radiotherapy, immunotherapy and autologous or allogeneic hematopoietic stem cell transplantations (HSCT). The general recommendation for patients is to relax and avoid intense exercise, regardless of the devastating consequences of neglecting physical exercise. Patients also go to relaxation by reducing their activity to avoid fatigue, which leads to loss of muscle strength and endurance. As a consequence of all, fatigue, vomiting, weight loss, anemia, depression, decreased aerobic capacity, muscle weakness, decreased physical function and poor quality of life are observed in HSCT recipients. It has been shown that physical exercises improve oxygen consumption, depression and fatigue, cardiorespiratory fitness, muscle strength and physical well-being in patients with hematologic malignancies who are at stages of various treatments. In literature, effects of upper extremity aerobic exercise training have been investigated in patients with spinal cord injury, neuromuscular diseases, claudication, hypertension, multiple sclerosis, heart failure, paraplegic patients and healthy individuals. Results of these studies has shown that upper extremity aerobic exercise training improves walking distance, increases oxygen pulse, muscle strength and endurance of upper extremity. No study was observed to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients, as we know. For this reason, our aim is to investigate the effects of upper extremity aerobic exercise training on exercise capacity and quality of life in HSCT recipients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 16, 2016

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 2, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

February 25, 2021

Status Verified

February 1, 2021

Enrollment Period

2.3 years

First QC Date

December 16, 2016

Last Update Submit

February 24, 2021

Conditions

Keywords

Hematopoietic stem cell transplantationAerobic exerciseQuality of LifeMuscle StrengthDepressionexercise capacitydyspneaanxietyfatiguepulmonary functions

Outcome Measures

Primary Outcomes (1)

  • functional exercise capacity evaluation

    Evaluated with 6-minute walking test

    6-week

Secondary Outcomes (9)

  • pulmonary functions test

    6-week

  • muscle strength

    6-week

  • cough strength

    6-week

  • physical activity level

    6-week

  • fatigue severity

    6-week

  • +4 more secondary outcomes

Study Arms (2)

Treatment group: aerobic exercise

EXPERIMENTAL

The upper extremity aerobic exercise training with an arm ergometer will be performed in the treatment group so that training intensity will be between 60% and 80% of the maximum heart rate, dyspnea perception will be 3-4 according to Modified Borg Scale and fatigue perception will be 5-6 according to Modified Borg Scale, training duration will be a 6-week.

Other: Upper Extremity Aerobic Exercise

Control group: deep breathing exercise

NO INTERVENTION

Deep breathing exercises combinated with arm movements will be given as a home schedule in the control group. Training duration will be a 6-week.

Interventions

Range of maximal heart rate is being followed by a polar band during supervised session each week. Aerobic exercise is being trained for 30 min-per/day, 3 days/week, 6 weeks. All sessions are being performed by a physiotherapist at cardiopulmonary rehabilitation department.

Treatment group: aerobic exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being an hematopoietic stem cell transplantation recipient during the intermediate/late post-transplant phase (\>100 days),
  • years of age
  • under standard medications.

You may not qualify if:

  • having a cognitive disorder,
  • orthopedic or neurological disease with a potential to affect functional capacity,
  • comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute infections or pneumonia,
  • problems which may prevent training such as visual problems and mucositis
  • having metastasis to any region (bone etc.)
  • having acute hemorrhage in the intracranial and / or lung and other areas
  • having any contraindication to exercise training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation

Ankara, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

DepressionDyspneaAnxiety DisordersFatigue

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Gülşah Barğı, MSc.

    Gazi University

    STUDY CHAIR
  • Meral Boşnak Güçlü, PhD.

    Gazi University

    STUDY DIRECTOR
  • Zübeyde Nur Özkurt, PhD.

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Münci Yağcı, PhD.

    Gazi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

December 16, 2016

First Posted

January 2, 2017

Study Start

April 1, 2016

Primary Completion

August 1, 2018

Study Completion

September 1, 2018

Last Updated

February 25, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.

Locations